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During cutaneous wound repair the epidermis avoids
the ®brin-rich clot; rather it migrates down the col-
lagen-rich dermal wound margin and over ®bro-
nectin-rich granulation tissue. The mechanism(s)
underlying keratinocyte movement in this precise
pathway has not been previously addressed. Here we
demonstrate that cultured human keratinocytes do
not express functional ®brinogen/®brin receptors,
speci®cally avb3. Biologic modi®ers known to
induce integrin expression or activation did not
induce adhesion to ®brin, ®brinogen, or its frag-
ments. Epidermal explant outgrowth and single epi-
dermal cell migration failed to occur on either ®brin
or ®brinogen. Surprisingly, ®brin and ®brinogen
mixed at physiologic molar ratios with ®bronectin
abrogated keratinocyte attachment to ®bronectin.
Keratinocytes transduced with the b3 integrin sub-
unit cDNA, expressed avb3 on their surface and
attached to and spread on ®brinogen and ®brin.
b-gal cDNA-transduced keratinocytes did not
demonstrate this activity. Furthermore, b3 cDNA-
transduced keratinocyte adhesion to ®brin was
inhibited by LM609 monoclonal antibody to avb3 in
a concentration-dependent fashion. From these data,
we conclude that normal human keratinocytes can-
not interact with ®brinogen and its derivatives due
to the lack of avb3. Thus, ®brinogen and ®brin are
authentic anti-adhesive for keratinocytes. This may
be a fundamental reason why the migrating epi-
dermis dissects the ®brin eschar from wounds.
Key words: adhesion/epidermis/®brinogen/integrins/wound
healing. J Invest Dermatol 117:1369±1381, 2001
D
uring the initial re-epithelialization of cutaneous
wounds, migrating epidermal cells dissect a pathway
between the ®brin clot in the wound space and the
collagen-rich dermis (Odland and Ross, 1968;
Clark, 1997). Once the migrating epidermal cells
reach the granulation tissue they cleave a pathway between the
®brin clot and the ®bronectin-rich granulation tissue. The
epidermis, thereby, ultimately dissects the clot from the wound.
One of the fundamental unanswered questions about re-epithelial-
ization is how the epidermis ®nds this cleavage plane between the
nonviable ®brin eschar and the viable dermis or granulation tissue.
Previous in vitro studies demonstrated that keratinocyte adhesion
and motility require expression of the appropriate cell surface
receptors for these extracellular matrix (ECM) molecules (Clark
et al, 1985; Woodley, 1996). Integrins compose one family of such
receptors (Adams and Watt, 1991). There are over 20 integrins that
mediate cell±ECM or cell±cell interactions. Each integrin is a
heterodimeric transmembrane protein, consisting of one a and one
b subunit in a noncovalent complex, which together specify ligand
binding (Yamada et al, 1996).
In normal human skin, major integrins expressed by keratino-
cytes are a2b1, a3b1, and a6b4 (Yamada et al, 1996). The a2b1
integrin is a type I collagen receptor, whereas the a3b1 and a6b4
integrins are laminin 5 receptors that form critical adhesions to the
basement membrane. In contrast, during re-epithelialization the
migrating epidermal cells upregulate integrins that ligate provisional
matrix proteins (Clark, 1990). These integrins include a5b1
(Cavani et al, 1993; Juhasz et al, 1993; Larjava et al, 1993; Gailit
et al, 1994), avb5 (Clark et al, 1996b; Gailit et al, 1994), and avb6
(Larjava et al, 1993; Clark et al, 1996b; Haapasalmi et al, 1996).
Keratinocytes presumably require such integrins for adhesion to
and migration on the provisional matrix proteins that occur in the
subepidermal stroma during re-epithelialization (Clark, 1990,
1996). This hypothesis is supported by in vitro evidence that
a5b1 mediates keratinocyte migration on ®bronectin (Kim et al,
1992) and avb5 mediates keratinocyte migration on vitronectin
(Kim et al, 1994). Despite the lack of direct evidence that integrins
function during re-epithelialization, most of the epidermal wound-
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healing studies listed above have demonstrated a correlation
between integrin appearance on the keratinocytes and the appro-
priate ECM ligand beneath the migrating epidermis, suggesting a
functional interaction.
Fibrinogen, the major provisional matrix protein present in the
wound space immediately after injury (Clark, 1996), is a
340,000 kDa hexamer composed of two Aa, two Bb, and two g
chains, and it circulates at approximately 3 g per l (Mosesson,
1992). Thrombin cleavage of ®brinopeptide A and B from the Aa
and Bb chains exposes binding sites that function cooperatively in
®brin polymerization (Mosesson, 1992). Endothelial cells and
®broblasts bind ®brinogen and ®brin through the avb3 integrin
in vitro (Gailit et al, 1997; Newman et al, 1996) and invade the ®brin
clot in vivo (Clark et al, 1996a; McClain et al, 1996). In contrast,
cultured keratinocytes do not produce the b3 integrin subunit
(Adams and Watt, 1991) and in vivo keratinocytes do not invade the
®brin-rich clot (Odland and Ross, 1968). Although the search for
avb3 on wound epidermal cells has not been the focus of previous
studies, we and others have reported that the receptor was not
present on keratinocytes during wound re-epithelialization (Cavani
et al, 1993; Gailit et al, 1994; Clark et al, 1996a).
Here, absence of avb3 was rigorously con®rmed in the
migrating epidermis of both human and porcine cutaneous wounds
and in cultured normal human keratinocytes using a monoclonal
antibody, speci®c for the avb3 complex in addition to a
monoclonal antibody speci®c for the b3 subunit. Most importantly,
we found that both ®brin and ®brinogen failed to support cultured
keratinocyte adhesion or migration and abrogated the ability of
keratinocytes to interact with ®bronectin. Transduction of b3
integrin subunit cDNA conferred on keratinocytes the ability to
express avb3 and to interact with ®brinogen and ®brin.
MATERIALS AND METHODS
Preparation and characterization of ®brinogen, ®brinogen
degradation products, and RGD peptides Puri®ed peak 1
®brinogen (Mosesson et al, 1973), ®brinogen fraction I-9 (Mosesson,
1974), and fragment D1 (Mosesson et al, 1996) were chromatographically
puri®ed from human plasma as described in the cited references.
Fragment E was isolated from a stage one plasmin digest of ®brinogen
(Meh et al, 1993). Preparations were screened for possible ®bronectin
contamination by Western blot analysis with polyclonal anti-®bronectin
(Dako, Carpinteria, CA). Residual ®bronectin was removed from these
preparations, when necessary, by adsorption with gelatin-Sepharose 4B
(Pharmacia, Piscataway, NJ). Residual ®bronectin as measured by
enzyme-linked immunosorbent assay (ELISA) in the puri®ed preparations
was < 0.001% wt/wt for peak 1 ®brinogen and E1; undetectable for I-9
and D1. In dose±response experiments the ELISA could detect as little as
10 pg ®bronectin per ml adsorbed to the wells. The ELISA used goat
anti-human ®bronectin (Cappel, Durham, NC) for the capture antibody,
rabbit anti-human ®bronectin (Gibco, Grand Island, NY) as the
detection antibody, and goat anti-rabbit IgG alkaline phosphatase
conjugate (Cappel) as the secondary antibody. The ®bronectin standard
was supplied by Biomedical Technologies (Stoughton, MA). No
®bronectin contamination could be detected in any puri®ed ®brinogen
preparations by Western blotting. The ®brinogen was > 95% clottable.
GRGDSP and GRGESP were synthesized using the ABI Model 431
A peptide synthesizer and FastMoc chemistry at the Center for Analysis
and Synthesis of Macromolecules (SUNY, Stony Brook).
Human keratinocyte culture Normal human keratinocytes were
obtained from neonatal foreskins and grown for two passages with
lethally irradiated 3T3-J2 cells (Rheinwald and Green, 1975) using a
modi®ed medium (Randolph and Simon, 1993). At the third passage
cells were resuspended in growth medium modi®ed by the addition of
serum to 10% and dimethyl sulfoxide to 10% and subsequently frozen in
liquid nitrogen. Keratinocyte cultures were characterized and determined
to be > 99% pure on the basis of characteristic polygonal morphology
and immuno¯uorescence detection of keratin-positive cells. For use the
frozen cells were quickly thawed at 37°C and grown in serum-free, low-
calcium (0.15 mM) medium keratinocyte growth medium (KGM) from
Clonetics (San Diego, CA). All experiments were done using fourth
passage keratinocytes. For the cell adhesion assay, the medium was
changed to keratinocyte basal medium (KBM) plus 0.1% Bovine
Albumin Fraction V (BSA) from ICN Pharmaceuticals (Irvine, CA),
100 U penicillin per ml and 100 mg streptomycin per ml from Gibco
BRL (KBM/BSA/PS) 24 h before the cell harvest.
Human endothelial cell culture Human dermal microvascular
endothelial cells were isolated from human neonatal foreskins as
described by Kubota et al (1992). Endothelial cell cultures were
characterized, and determined to be > 99% pure on the basis of
characteristic cobblestone morphology, immunodetection of von
Willebrand factor, and uptake of acetylated low-density lipoprotein.
Cell adhesion assay
Method 1: adhesion assay under wash conditions Ninety-six-well plates from
Flow Laboratories (McLean, VA) were coated with either ®brinogen,
®brinogen I-9, D1, E1, or other matrix proteins, including ®bronectin,
type IV collagen, and laminin from Gibco BRL; type I collagen
(Vitrogen 100) from Celtrix (Santa Clara, CA); and BSA from ICN
Pharmaceuticals, Inc. Each protein was diluted in 50 mM Tris, pH 7.4,
150 mM NaCl2, 0.1% NaN3 (TBS/NaN3) to protein concentrations
described in the Results section and added to individual wells at a 70 ml
volume. After 20 h at 4°C for adsorption, all plates were washed with
phosphate-buffered saline (PBS) three times using a Nunc Immunowash.
Fibrin was made by mixing ®brinogen and 0.1 U thrombin per ml (New
York Blood Center) in a solution of TBS/NaN3 plus 10 mM CaCl2
(TBS/NaN3/Ca), and added to individual wells at a 70 ml volume and
then incubated at 37°C for 20 h. These plates were washed two times
with TBS/NaN3 and then once with PBS. All wells were blocked with
20 mg per ml BSA, 0.1% NaN3 for 2 h at 25°C, and then washed again
three times with PBS. For most cell adhesion assays, 1 3 104 viable
keratinocytes in 100 ml volume were added to each well and then
incubated for 1 h at 37°C in 5% CO2, 95% air, and 100% humidity.
After incubation, the adherent cells were ®xed by adding 100 ml of 2%
glutaraldehyde for 10 min at 25°C, and then the plates were gently
washed with PBS three times followed by ®ve times with distilled water
(Tonnesen et al, 1989). The plates were dried and stained with 0.1%
crystal violet in 0.2 M minimum essential salts (MES) (Sigma), pH 6.0
for 20 min at 25°C with agitation. Plates were washed ®ve times in
distilled water, and dried. Stained cells were observed under the Nikon
phase contrast microscope, and solubilized with 10% acetic acid by
shaking for 15 min at 25°C. To determine the number of adherent cells,
the solution optical density was measured on a Molecular Devices
Microplate reader (Menlo Park, CA) at wavebands of 590±450 nm.
Results are presented as the mean 6 SD from four replicate wells for
each condition assayed.
Method 2: adhesion assay under centrifugal force conditions Twenty microliters
of matrix protein solutions at the concentrations indicated in the Results
section were incubated (37°C, 2 h) on polystyrene sheets as described
(Calof and Lander, 1991). Sheets were washed, blocked with heat-
denatured (65°C) BSA (10 mg per ml, 20 ml per well) by incubating at
37°C for 2 h. Thrombin (5 U per ml) was added to wells containing
®brinogen and incubated (37°C, 30 min) and the plates were then
washed. Either human keratinocytes or T24 human bladder carcinoma
cells (American Tissue Culture Collection, Rockville, MD) as a positive
control were prelabeled with 35S-express label 50 mCi per ml for 3 h and
then distributed to wells in 20 ml aliquots of 1.5 3 105 cells per ml
RPMI plus 1 mg BSA per ml. Test plates were immediately centrifuged
up to 53 3 g and then incubated for 1 h, at 37°C to allow cell adhesion
to occur. Plates were then inverted, centrifuged (53 3 g, 8 min) to
remove nonadherent cells, ®xed in 3% formaldehyde in PBS, dried, and
radioactivity quanti®ed by phosphoimager analysis using ImageQuant
software (Molecular Dynamics, Sunnyvale, CA). Results are presented as
the mean 6 SD of phosphoimager units from six replicate wells.
Measurement of ®bronectin adsorbed to plastic wells in the absence
and presence of ®brinogen or ®brin
Isotopic assay Ninety-six-well plates (Removawell Strips, Dynatech
Laboratories, Chantilly, VA) were coated with 70 ml of appropriate
provisional matrix solution. Each 100 mg ®bronectin per ml contained
0.1078 mCi of I-125 labeled ®bronectin, speci®c activity = 7.74 mCi per
mg (ICN Biomedicals, Irvine, CA). The solutions, ®bronectin with or
without ®brinogen or ®brin, were incubated in the plates overnight at
37°C. The next day, wells were washed three times with PBS and the
amount of adsorbed ®bronectin in the wells were counted by
scintillation (LKB 1214 Rackbeta Flexi-Vial, Perkin Elmer Instruments,
Shelton, CT).
Enzyme-linked-streptavidin biotin assay Plasma ®bronectin was conjugated
with E2-Link Sulfo-NHS-LC-Biotin (Pierce, Rockford, IL) using the
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manufacturer's protocol. Ninety-six-well plates (Immulon 4, Dynatech
Laboratories) were coated with 70 ml of various concentrations of
biotinylated ®bronectin alone or with 100 mg ®brin per ml overnight at
37°C. The next day, plates were washed three times with PBS. To block
residual protein binding sites on the plastic surface each well was
incubated with 2% BSA for 2 h at room temperature. Next wells were
washed with PBS plus 0.02% Tween 20 (PBS Tween) three times and
then incubated with 100 ml of alkaline phosphatase conjugated
streptavidin (Vector Laboratories, Burlingame, CA) at a dilution of
1:10,000 for 30 min at 25°C. After washing three times with PBS
Tween, the wells were incubated with Fast Red (BioGenex, San
Ramon, CA) for 30 min at 25°C. The optical density of the solution
was read on a Molecular Devices Microplate reader at 405 nm.
Effects of transforming growth factor (TGF)-b, epidermal growth
factor (EGF), 12-O-tetradecanoyl-phorbol-13-acetate (TPA),
dibutyryl cyclic adenosine monophosphate (AMP), and divalent
cations on human keratinocyte adhesion to ®brinogen, FGI-9, D1,
E1, ®brin, and other ECM proteins Effects of TGF-b and EGF were
examined by incubating cells with TGF-b1 (Celtrix), TGF-b2 (Genzyme
Tissue Repair, Framingham, MA), or EGF (Clonetics) in KBM/BSA/PS
for 24 h before the cell harvest and during the 1 h cell adhesion assay
(method 1). The effects of TPA, dibutyryl cyclic AMP, and divalent
cations (MgCl2, CaCl2) were examined by adding these reagents to the
KBM/BSA/PS medium during the 1 h cell adhesion assay only. The
concentration of each reagent indicated in the results was chosen based
on previously reported data (Freed et al, 1989; Chen et al, 1993; Lange et
al, 1994; Iwasaki et al, 1994; Fujii et al, 1995; Hertle et al, 1995).
Cell migration assay
Method 1: modi®ed phagokinetic migration assay of human keratinocytes (O'Keefe
et al, 1985) Colloidal gold solution was prepared by mixing 3 ml
36.5 mM Na2CO3, 0.9 ml 14.5 mM HAuCl4 (Sigma) and 5.5 ml H2O,
heated to boiling and adding 0.9 ml of 0.1% formaldehyde. Acid-washed
12 mm glass coverslips were dipped sequentially in 1% BSA and 100%
ethanol and then dried. Coverslips were incubated 45 min with 0.5 ml
of freshly prepared gold colloid solution, washed once with PBS,
overlaid with 75 ml of PBS solution containing ECM proteins, incubated
for 2 h at 37°C in a humidi®ed environment, washed once with PBS,
and then placed in wells of a 24 well plate containing 0.5 ml KGM
medium.
Human foreskin keratinocytes were maintained in KGM (Clonetics)
prior to assays. Cells were harvested by trypsinization, resuspended in
KGM (2 3 104 cells per ml) and 0.5 ml of the suspension added to each
well. After 16±18 h of incubation the coverslips were ®xed in situ by
underlaying the medium with 3.7% formaldehyde in 10% sucrose,
washed once with H2O and stained with 3 mM ethidium homodimer
(Molecular Probes, Eugene, OR) solution.
The extent of cell migration was determined by measuring the area of
gold cleared by the cells. Three to ®ve ®elds per coverslip were
Figure 1. Histology and integrin expression
of re-epithelializing porcine wounds. Full-
thickness paravertebral skin wounds were
harvested on day 5 or 7 and bisected. One-half
was formalin ®xed and stained with Masson
trichrome and the other half was quick frozen in
OCT with liquid nitrogen. (a) Five day ®xed
wound section stained with Masson trichrome.
The arrow resides on the tip of the migrating
epidermis and points in the direction of migration.
The dermis at the wound margin is indicated by
the letter (d) and newly forming granulation tissue
is noted by (gt). (b) Frozen tissue specimen of a
5 d wound stained for b1 integrin subunit with
monoclonal antibody 4B4. (c) Frozen tissue
specimen of a 5 d wound stained for avb5
integrin with monoclonal antibody P1F6. (d)
Frozen tissue specimen of a 5 d wound stained for
avb3 integrin with monoclonal antibody 23C6.
Bright staining of avb3-positive patches beneath
the migrating epidermis are capillary sprouts as
previously described (Clark et al, 1996a). (e)
Frozen tissue specimen of a 7 d wound stained for
avb5 integrin with monoclonal antibody P1F6.
( f ) Frozen tissue specimen of a 7 d wound
stained for avb3 integrin with monoclonal
antibody 23C6. In a±d, e denotes wound
epidermis and the arrow indicates the direction of
migration. Scale bar: (a) 200 mm; (b±f ) 100 mm.
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photographed under dark®eld and ¯uorescent illumination using a 5 3
objective on a Zeiss Axioskop equipped with a Photometrics CCD
camera. The percentage of total area cleared by the cells was determined
by tracing each phagokinetic track and calculating the sum of these areas
using an image processing program (NIH Image software). The ``cleared
area'' was divided by the total area of the ®eld to give the ``percent
cleared''. Because the number of cells per ®eld varied, the ``normalized
migration index'' was calculated by dividing the ``percent cleared'' by
the number of cells per ®eld as visualized by ethidium homodimer
staining. Each experimental point represents the mean of three to ®ve
®elds and error bars are the SEM.
Method 2: keratinocyte outgrowth into ®brin or collagen gels Foreskin biopsies
(» 2 mm diameter) were placed on to preformed gels (0.5 ml) of type I
(95%) and type III (5%) bovine collagen (2.4 mg per ml; Vitrogen,
Collagen) or ®brin (3 mg per ml puri®ed human ®brinogen to which
thrombin 5 U per ml was added) in Dulbecco's minimal Eagle's medium
containing 10% fetal bovine serum. Fetal bovine serum had been
depleted of plasma ®bronectin by duplicate passages over a gelatin-
af®nity column (Van De Water et al, 1981). Explants were incubated for
3 d (37°C), ®xed (3% paraformaldehyde in PBS), stained, and the area of
epidermal outgrowth determined by photographing the explants and
quantifying with NIH Image. The increase (%) in outgrowth area was
calculated as: [(Area of total explant at day 3 ± area of original explant)/
area of original explant] 3 100%.
Fluorescence-activated cell sorter (FACS) analysis for b3 integrin
subunit and avb3 integrin Cultures of normal adult human
keratinocytes and ®broblasts were analyzed for the cell surface expression
of b3 integrin subunit and avb3 integrin by quantitative ¯ow cytometry
as described previously (Gailit and Clark, 1996; Gailit et al, 1996). The
monoclonal antibody 7E3, against the b3 subunit, was supplied by Barry
Coller (Mount Sinai Medical Center, NY) (Coller, 1985; Charo et al,
1987). The monoclonal antibody LM609, against avb3 integrin, was
kindly provided by David Cheresh (Research Institute of Scripps Clinic,
La Jolla, CA) (Cheresh and Spiro, 1987). Control antibodies included
anti-a5 (monoclonal antibody 16) kindly provided by Kenneth Yamada
(National Institute of Dental and Craniofacial Research, Bethesda, MD)
(Akiyama et al, 1989) and nonimmune mouse IgG (Dako).
Porcine cutaneous wound model Full-thickness excisional wounds
were made by an 8 mm circular punch into the paravertebral skin of a
Yorkshire pig; dressed with Tegaderm, a polyurethane occlusive dressing;
and harvested as previously described (Welch et al, 1990). Specimens
from all wound sites were bisected vertically. One-half of each specimen
was ®xed in formalin, paraf®n embedded, sectioned at 5 mm, and stained
with Masson trichrome to delineate the relationship of the migrating
epidermis and clot during wound repair. The other half was frozen in
liquid nitrogen for immuno¯uorescence studies aimed at determining
whether avb3 integrin was present or absent in the epidermis during re-
epithelialization.
Immuno¯uorescence studies Frozen sections were prepared for immuno-
¯uorescence as previously described (Folkvord et al, 1989). All antibodies
were used at dilutions that gave maximal speci®c ¯uorescence and
minimal background ¯uorescence on frozen tissue specimens. Bound
Figure 2. Protein dose±response curves of human keratinocyte
adhesion to ®brinogen, its fragments and other ECM proteins.
Cell adhesion assay was done using method 1. Keratinocyte adhesion was
measured with protein coat concentrations up to 500 mg per ml of
®brinogen (FG), FGI-9, and up to 100 mg per ml of ®brinogen
fragments D1 and E1, type I collagen (COL-I), ®bronectin, type IV
collagen (COL-IV), and laminin (LN). One 3 104 viable cells were
added to each well, and incubated for 1 h at 37°C. Data points are the
mean 6 SD of quadruplicate samples. The results presented here are
representative of three independent experiments.
Figure 3. Fibrin dose±response of the adhesion of human
keratinocytes and microvascular endothelial cells. (A) Human
keratinocytes; (B) microvascular endothelial cells. The adhesion assay was
done using method 1 except 200 mM boric acid, pH 4.0 was used to
decrease the crystal violet staining of ®brin. Optical density shown here
was the difference between the test condition and plates coated with
®brin without cell addition. Data points are the mean 6 SD of
quadruplicate samples. The data shown here are representative of three
independent experiments.
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antibody was detected by the avidin±biotin-complex technique as
previously described (Folkvord et al, 1989). Immuno¯uorescence controls
included sections stained with an irrelevant monoclonal antibody instead
of the primary antibody, as well as sections in which either the primary
and/or secondary antibody(ies) was omitted from the staining procedure.
Monoclonal antibodies 7G2 speci®c for the integrin subunit b3
(Gresham et al, 1989); 23C6 speci®c for the avb3 complex (Horton et al,
1985); P1F6 (Gibco BRL) and P3G2 speci®c for the avb5 complex
(Wayner et al, 1991); and 4B4 (Coulter, Hileah, FL) speci®c for the b1
subunit (Matsuyama et al, 1989) were used to detect integrins of interest.
Although these antibodies are known to be speci®c for distinct integrins
in human tissues, we tested these antibodies for their ability to precipitate
the appropriate integrin from cultured pig ®broblasts (Gailit et al, 1993).
Vectashield mounting medium (Vector Laboratories) was used to
retard quenching. Slides were photographed on 35 mm Tmax 400 ®lm
(Eastman Kodak, Rochester, NY) using a Nikon Microphot FXA
epi¯uorescence microscope equipped with a halogen light source, a 470±
490 nm excitation ®lter and a 515 nm barrier ®lter for ¯uorescein
emission.
Retrovirus-mediated transduction of b3 integrin subunit cDNA
into normal human keratinocytes The BABE retroviral vector is
derived from Moloney murine leukemia virus and contains a selectable
marker, puromycin (Morgenstern and Land, 1990). The 3.8 kb cDNA
containing the full length human b3 integrin subunit (Fitzgerald et al,
1987) (kindly provided by David Cheresh) was inserted into pBABE at
the Sal1 site. Infectious recombinant retrovirus was generated in y CRE
cells followed by transinfection into GP + envAM12 cells according to
established protocol (Miller, 1992). GP + envAM12 producers
(Markowitz et al, 1988) were selected with puromycin (Sigma) and
individual clones tested. The clone with the highest titer, as measured in
3T3 cells (1 3 107 CFU per ml) was used. A BABE retrovirus encoding
the gene for b-galactosidase (b-gal) was used as a control (Ghazizadeh et
al, 1997). Keratinocytes were transduced (Garlick et al, 1991) and
expanded in a serum-containing medium (Wu et al, 1982) without the
use of puromycin. Marker rescue assay for helper virus was negative.
Protein expression of avb3 on the cell surface was screened by avidin±
biotin immuno¯uorescence technique using 23C6 speci®c for avb3
(Horton et al, 1985), biotinylated anti-mouse IgG (Vector Laboratories)
and ¯uorescein streptavidin (Vector Laboratories). FACS analysis was
used to con®rm positive cultures.
Cell adhesion assay was done by method 1. Vitronectin was purchased
from Sigma. Adhesion of b3 cDNA-transduced keratinocytes to ®brino-
gen or ®brin was dependent on cell density and was best up to 50±60%
con¯uence of the cultures. Therefore, fourth passage keratinocytes were
cultured in KGM for 3±4 d up to 50±60% con¯uence. Medium was
changed to KBM 24 h prior to the cell harvest. b-gal cDNA-transduced
keratinocytes were used as control cells. Stained cells were photographed
with a Nikon inverted microscope at 200 3 magni®cation. Inhibition
assay of the cell adhesion was done by incubating cells with various
concentrations of GRGDSP or GRGESP peptides (see Materials and
Methods above) for 30 min at 25°C before adding cells to the wells.
Alternatively, monoclonal antibody to avb3 (LM609), anti-a5 mono-
clonal antibody (no. 16), anti-®bronectin polyclonal antibody (Cappel) or
normal mouse IgG1 were added to the cells.
RESULTS
The migrating epidermis of wounds avoids the ®brin eschar
and fails to express the ®brin receptor avb3 In early
cutaneous wound healing the migrating epithelial tongue
descended along the dermal wound margin and newly forming
granulation tissue separating the ®brin clot from viable tissue
(Fig 1A). The migrating epidermis expressed markedly increased
b1 integrins (Fig 1B) as previously reported (Clark, 1990; Cavani
et al, 1993; Juhasz et al, 1993; Gailit et al, 1994), the avb5
vitronectin receptor (Figs 1C, E) (Clark et al, 1996b; Gailit et al,
1994), but no avb3 integrin as judged by monoclonal antibody
23C6 (Figs 1D, F). Importantly, 23C6 and 7G2 detected
remarkable avb3 and b3 subunit staining, respectively, on the
tips of capillary sprouts in the same 5 d wound tissue sections where
the epidermis was not stained (Fig 1D and Clark et al, 1996a,
respectively). Both porcine (Fig 1) and human (not shown) wound
epidermis failed to express avb3, whereas both expressed avb5
during the ®rst week of healing (Fig 1C, E) (Gailit et al, 1994;
Clark et al, 1996b). The dissection of the ®brin clot from the
wound space continues until the ®brin eschar is sloughed from the
wound. Surprisingly, the mechanism by which the migrating
epidermis avoids the ®brin clot has not been previously addressed.
Therefore, we sought to delineate the interactions of human
keratinocytes with ®brin, ®brinogen, and its fragments.
Figure 4. Keratinocyte and T24 bladder carcinoma cell adhesion
to ®brin and ®bronectin. Human keratinocytes (A) or T24 human
bladder carcinoma cells (B) were applied to wells (3 3 103 cells in 20 ml)
precoated with ®brinogen at the indicated concentrations (mg per ml)
followed by thrombin (5 U per ml, 30 min), plasma ®bronectin (10 mg
per ml), or BSA (10 mg per ml). Cells were incubated (37°C, 1 h),
inverted, and centrifuged (53 3 g, 8 min) to dislodge nonadherent cells.
Data are presented as the mean 6 SD of cell-associated radioactivity
(phosphoimager units 3 10±4) bound to the plates. Binding of T24 cells
to 50 mg ®brin per ml and to ®bronectin was statistically greater than
keratinocyte binding to these surfaces (p < 0.01 and p < 0.0001,
respectively) as judged by the Student's t-test.
Table I. Quantitative FACS analysis of b3 integrin subunit
and avb3 integrin expression by adult human keratinocytes
and dermal ®broblasts
Monoclonal
antibody
Relative no. of molecules/cell
(MESF)a
Keratinocytes Fibroblasts
7E3b NSd 13,950
LM609c NS 14,700
aMESF values are related to the number of integrin molecules on the cell surface
as previously described (Gailit and Clark, 1996).
bMonoclonal antibody 7E3 reacts with b3 integrin subunit.
cMonoclonal antibody LM609 reacts with avb3.
dNonsigni®cant MESF values (< 500).
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Human keratinocytes fail to interact with ®brinogen,
FGI-9, D1, E1, and ®brin but adhere to other ECM
proteins Human keratinocyte adhesion to various ECM
proteins was determined using the cell adhesion assay in method
1. As shown in Fig 2, human keratinocytes failed to adhere to
®brinogen or its fragments at any concentration examined. In
contrast, keratinocytes adhered well to type I collagen, ®bronectin,
type IV collagen, and laminin in a concentration-dependent
manner. Keratinocyte adhesion was maximum at 10 mg per ml
of type I collagen and ®bronectin, and at 20 mg per ml of type IV
collagen and laminin (Fig 2). Keratinocytes adhered better to type I
collagen and ®bronectin than to type IV collagen and laminin.
These results were consistent with previously reported results
(Clark et al, 1985; Kubo et al, 1987). Human keratinocytes also did
not adhere to ®brin (Fig 3A), whereas human microvascular
endothelial cells did (Fig 3B). Visual examination of the assay plates
coated with BSA, ®brinogen, or ®brin con®rmed that negligible
(< 2%) keratinocytes bound to these substrata.
Bladder carcinoma T24 cells, but not human keratinocytes,
adhere to ®brin and ®bronectin in a centrifugal force
assay To con®rm the inability of keratinocytes to adhere to
®brin, we used a second adhesion assay in which centrifugal force
substituted for washing off nonadherent cells. In this assay human
keratinocytes again failed to adhere to ®brin over a range of coating
concentrations from 3.1, 12.5, and 50 mg per ml (Fig 4A), but
adhered well to ®bronectin at 10 mg per ml (Fig 4A). By contrast,
human bladder carcinoma T24 cells, which express avb3 (Senger
et al, 1994), adhered in a concentration-dependent fashion to ®brin
as well as to ®bronectin (Fig 4B). Experiments in which plates
were centrifuged at a higher force (133 3 g instead of 53 3 g)
yielded identical results for keratinocytes. Somewhat lower, albeit
signi®cant, binding was observed for T24 cell attachment to ®brin
at this higher ``g'' force (data not shown). Therefore, these results
con®rmed the inability of human keratinocytes to adhere to ®brin
under conditions of uniform centrifugal force.
Human keratinocytes fail to express cell surface b3 integrin
subunit and avb3 as shown in Table I FACS analysis revealed
no signi®cant expression of the b3 integrin subunit on
keratinocytes. The monoclonal antibody 7E3 that recognizes the
b3 subunit (Coller, 1985; Charo et al, 1987) and the monoclonal
antibody LM609 speci®c for integrin avb3 (Brooks et al, 1994;
Cheresh and Spiro, 1987; Clark et al, 1996a) both failed to detect
the b3 subunit or avb3 integrin on the keratinocyte cell surface. In
contrast, adult human dermal ®broblasts and endothelial cells (not
shown) expressed clearly detectable levels of the b3 subunit and
avb3 integrin.
TGF-b, EGF, TPA, dibutyryl cyclic AMP, and divalent
cations fail to induce human keratinocyte interaction with
®brinogen, its fragments, or ®brin As TGF-b, EGF, TPA,
dibutyryl cyclic AMP, and divalent cations are known to be
inducers or activators of integrin receptors (Freed et al, 1989; Chen
et al, 1993; Iwasaki et al, 1994; Lange et al, 1994; Fujii et al, 1995;
Hertle et al, 1995), we examined the effects of these reagents on
human keratinocyte adhesion to ®brinogen, its fragments, ®brin
and other ECM proteins. TGF-b2 at 5 ng per ml failed to induce
human keratinocyte adhesion to ®brinogen, its fragments or ®brin,
whereas it signi®cantly increased adhesion to type IV collagen,
laminin (Fig 5A), and ®bronectin (data not shown). TGF-b1 gave
essentially the same results as TGF-b2 (data not shown). EGF at
10 ng per ml failed to induce human keratinocyte adhesion to
®brinogen, FGI-9, or ®brin (data not shown) as well as laminin.
EGF did, however, stimulate a small but signi®cantly increased
Figure 5. Effects of TGF-b, EGF, TPA, dibutyryl cyclic AMP and divalent cations on human keratinocyte adhesion to ®brin,
®brinogen, its fragments and other ECM proteins. (A) Five nanograms per ml TGF-b2; (B) 10 ng per ml EGF; (C) 80 nM TPA or 10 mM
dibutyryl cyclic AMP; (D) 2 mM MgCl2 or 2 mM CaCl2. Cell adhesion assay method 1 was used for these investigations (see Materials and Methods
section). After the appropriate preincubation (see Materials and Methods), 1 3 104 viable cells were added to wells coated with either 100 mg per ml
®brinogen (FG), FGI-9 or ®brin, or 20 mg per ml D1, E1, type I collagen (COL-I), type IV collagen (COL-IV), ®bronectin, or laminin (LN) and
incubated for 1 h. The OD value shown is the total OD minus the BSA control. Adhesion of the treated cells was compared with that of cells kept in
control medium (KBM/BSA/PS). Data points are the mean 6 SD of quadruplicate samples. The results presented here are representative of three
independent experiments. In (A), keratinocyte adhesion to type IV collagen and to laminin was increased by TGF-b (p < 0.0001 and p < 0.01,
respectively, as judged by the Student's t-test). In (B), epidermal cell adhesion to type I collagen was increased by EGF (p < 0.01). In (C), keratinocyte
adhesion to type I and to type IV collagen was increased by TPA (p < 0.05 and p < 0.0001, respectively). In (D), epidermal cell adhesion to type I
collagen was increased by MgCl2 and decreased by CaCl2 (p < 0.01 and p < 0.0001, respectively). Adhesion to type IV collagen and to ®bronectin was
increased by MgCl2 (p < 0.0001 and p < 0.05, respectively). Adhesion to laminin was slightly increased by CaCl2 (p < 0.01).
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adhesion to type I collagen (Fig 5B) in agreement with previous
reports that EGF increases keratinocyte a2b1 integrin, a collagen
receptor (Chen et al, 1993). TPA (80 nM) failed to induce human
keratinocyte adhesion to ®brinogen, FGI-9, or fragments D1 or E1,
but increased adhesion to type IV collagen substantially and
induced a small but signi®cant increase in adhesion to type I
collagen (Fig 5C). These data are in concert with previous data
that TPA induces the a2b1 collagen receptor gene (Xu et al, 1996).
Dibutyryl cyclic AMP did not affect adhesion of the human
keratinocytes to any matrix protein (Fig 5C). Neither 2 mM
MgCl2 nor 2 mM CaCl2 induced human keratinocyte adhesion to
®brinogen or FGI-9. In contrast, 2 mM MgCl2 increased
keratinocyte adhesion to type I and IV collagen, whereas 2 mM
CaCl2 decreased keratinocyte adhesion to type I collagen (Fig 5D).
Lack of keratinocyte attachment to ®brinogen, FGI-9, and ®brin
under all these conditions was always con®rmed by visual
examination.
Keratinocytes fail to interact with physiologic composites of
®bronectin with ®brinogen or ®brin As in vivo ®brin clots
contain substantial ®bronectin (»1:10 molar ratio with ®brin) the
ability of keratinocytes to adhere to ®bronectin±®brin or ®bro-
nectin±®brinogen complexes was investigated. At physiologic
molar ratios ®brinogen and ®brin completely abrogated the
ability of normal human keratinocytes to interact with ®bro-
nectin (Fig 6A). Even at 1:1 molar ratios keratinocyte adhesion to
®bronectin±®brin or ®bronectin±®brinogen composites was far less
than adhesion to ®bronectin alone (Fig 6A). These data were not
attributable to less ®bronectin being adsorbed to plastic surfaces in
the presence of ®brin or ®brinogen. In fact, ®bronectin adsorption
to plastic surfaces was little affected by either ®brinogen or ®brin as
judged by radioisotope or ELISA studies (Fig 6B, C, respectively).
Keratinocytes fail to migrate on ®brinogen and migrate
poorly on ®brin clots Migration of keratinocytes was observed
in two settings, a planar surface and on three-dimensional protein
gels. In the ®rst assay, migration of individual cells was analyzed by
quantifying the extent to which cells ``cleared'' a lawn of gold
particles, the so-called phagokinetic assay. In the second assay, the
sheet migration of epidermal keratinocytes, growing out of a tissue
fragment, was analyzed. Signi®cant keratinocyte migration was
observed on gold-treated coverslips coated with type I collagen or
with plasma ®bronectin (Fig 7A). Consistently more robust
migration was observed on collagen than ®bronectin, shown here
at 25 mg per ml, a concentration that saturated the coverslips. No
signi®cant difference in keratinocyte migration was noted when
cells were plated on plasma or cellular ®bronectin, or on a mixture
of ®bronectin variants (data not shown). Keratinocytes never
migrated on ®brinogen (25 mg per ml) in the presence or absence
of thrombin (Fig 7A). It remained possible that keratinocytes could
migrate as an epidermal sheet more effectively than as single cells, a
Figure 6. Failure of keratinocytes to interact with ®bronectin/
®brinogen and ®bronectin/®brin composites. (A) Keratinocyte
adhesion to composites of 100 mg per ml ®brin or ®brinogen and 10 or
100 mg ®bronectin per ml dried on to plastic wells was compared with
adhesion on surfaces coated with the individual proteins. The adhesion
assay was done using method 1 except 200 mM boric acid, pH 4.0 was
used to decrease the crystal violet staining of ®brin. Optical density
shown here was the difference between the test condition and plates
coated with ®brin without cell addition. Data points are the mean 6 SD
of quadruplicate samples. The data shown here are representative of three
independent experiments. (B) Amount of isotopically labeled ®bronectin
adsorbed on to plastic wells in the presence or absence of ®brinogen or
®brin. Histograms represent the mean 6 SD of quadruplicate samples.
The data shown are representative of three independent experiments. (C)
Amount of ®bronectin adsorbed on to plastic wells in the presence or
absence of ®brinogen or ®brin as judged by an enzyme-linked
streptavidin±biotin assay. Data points are the mean 6 SD of
quadruplicate samples. The data shown are representative of three
independent experiments.
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phenomenon that would not be observed in the phagokinetic assay.
When biopsies of human foreskin were placed on to three-
dimensional protein matrices, a modest 20% outgrowth was
observed on gels made from highly pure ®brinogen compared
with a robust 78% outgrowth on type I collagen gels (Fig 7B). The
outgrowth on collagen gels was, in fact, statistically greater than on
®brin gels (p < 0.0001 by the Student's t-test).
Keratinocytes transduced with b3 integrin subunit cDNA
adhere to ®brinogen and ®brin Cell surface expression of
avb3 was detected with the b3 cDNA-transduced keratinocytes
by the avidin±biotin immuno¯uorescence technique (Fig 8A),
whereas b-gal cDNA-transduced keratinocytes (control) were
negative for avb3 (Fig 8B). This was con®rmed by FACS
analysis (Figs 8C, D). Two populations of b3-transduced cells
were observed on FACS analysis, one positive and one negative for
avb3 (Fig 8C). This was in concert with positive and negative
populations observed in cultured cells with immuno¯uorescence
technique. Typically, cells at the periphery of a colony were
positive and those at the center of a colony were negative (data not
shown). b3 cDNA-transduced human keratinocytes attached to
and spread on ®brinogen and ®brin compared with the control
b-gal cDNA-transduced keratinocytes (Figs 9 and 10, respec-
tively). b3 cDNA-transduced keratinocytes also attached to
vitronectin signi®cantly better than the control cells (Fig 9) and
spread substantially more (Fig 10). A slight increase of cell
attachment and spreading to ®bronectin was also observed with
the b3 cDNA-transduced keratinocytes compared with control
cells (Figs 9 and 10). The adhesion of b3 cDNA-transduced
keratinocytes to ®brin was inhibited by RGD peptides (Fig 11A)
and LM609 monoclonal antibody to avb3 (Fig 11B) in a
concentration-dependent fashion, but not by RGE peptides
(Fig 11A) nor monoclonal antibody to a5, nonimmune mouse
IgG1 or rabbit polyclonal antibody to human ®bronectin (Dako)
(Fig 11B). These results indicate that the attachment of b3-
transduced keratinocytes to ®brin was speci®c for one of three
RGD binding sites in ®brin (Cheresh et al, 1989) and mediated
through the avb3 integrin receptor (Cheresh and Spiro, 1987).
DISCUSSION
When the basement membrane is destroyed by cutaneous injury,
epidermal cells from the wounded edges of the epidermis leave the
basement membrane and migrate over provisional matrix proteins
that coat the type I collagen bundles along the cut surface of the
wound margin (Clark, 1996). In doing so, the migrating
keratinocytes avoid the ®brin clot eventually dissecting the ®brin-
laden eschar from the wound. The ®brinolytic system is necessary
for the wound epidermis to cleave ®brin from its migratory
pathway (Bugge et al, 1996; Rùmer et al, 1996). In addition, matrix
metalloproteinases are also probably important for keratinocyte
penetration under the ®brin clot (Saarialho-Kere et al, 1993, 1994).
Nevertheless, how the keratinocytes ®nd the migration pathway is
a fundamental, unanswered question.
Tissue cells often use integrin cell surface receptors for adhesion
and migration on ECM molecules (Lauffenburger and Horwitz,
1996). The avb3 integrin was originally characterized as a receptor
for vitronectin, a plasma protein (Hynes, 1992) and later found to
bind ®brinogen as well as other provisional matrix proteins
(Cheresh and Spiro, 1987; Cheresh, 1987). Whereas platelet and
megakaryocyte aIIbb3 integrin binds ®brinogen and ®brin (Shattil
et al, 1994), avb3 is the only integrin of tissue cells known to bind
these proteins (Chen et al, 1995). Thus, the in vivo observation that
keratinocytes avoid the ®brin clot coupled with the absence of
avb3 on keratinocytes in vitro and in vivo predict that keratinocytes
may not bind ®brinogen or ®brin; however, the interaction of
keratinocytes with ®brin or ®brinogen has not yet been conclu-
sively de®ned. For example, in a recent paper human keratinocytes
apparently bound to ®brin (Weiss et al, 1998); however, the cells
were allowed to sit on protein-coated surfaces for up to 30 h, a
suf®cient time for keratinocytes to remove or alter the protein coat.
In this study we extend prior observations that the migrating
wound epidermis does not express the avb3 (Cavani et al, 1993;
Gailit et al, 1994; Clark et al, 1996a) by utilizing a monoclonal
antibody to b3 (7G2) and a monoclonal antibody to avb3 (23C6)
in both human and porcine cutaneous wounds. Both monoclonal
antibodies gave identical results. Furthermore, the capillary tips of
blood vessels undergoing angiogenesis in 5 d wounds stained
brightly for avb3 as previously reported by us (Clark et al, 1996a)
and provided an internal positive control for avb3 staining.
Figure 7. Keratinocyte migration on ®brinogen, ®brin, type I
collagen, and ®bronectin. (A) Phagokinetic migration of human
keratinocytes on ®brinogen (FG), collagen (COL), or ®bronectin.
Keratinocytes were incubated on gold-coated coverslips that were treated
with either type I collagen (25 mg per ml), ®bronectin (25 mg per ml),
®brinogen (25 mg per ml), or BSA (10 mg per ml). The migration index
was determined by measuring the area of gold cleared by the cells (see
Materials and Methods for details). As judged by the two-tailed Student's
t-test there was statistically more keratinocyte migration on collagen and
®bronectin compared with the BSA control (p < 0.0001 for both
comparisons). In contrast, there was statistically less migration on
®brinogen compared with the BSA control (p < 0.01). (B) Analysis of
keratinocyte outgrowth from foreskin explants. Biopsies of neonatal
foreskin (2 3 2 mm) were placed on to gels prepared from either ®brin
(3 mg per ml) or collagen (2.4 mg per ml). Outgrowth was followed
over 3 d (37°C). Samples were ®xed and the percent increase in
outgrowth area from the biopsy was determined by image analysis.
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Cultured human keratinocytes failed to interact with ®brin,
®brinogen, or its fragments under any condition tested. Alteration
of protein concentration and cell number (data not shown) could
not overcome the keratinocyte lack of af®nity for ®brin,
®brinogen, or its fragments. The lack of adhesion was also not
attributable to an artifact of our adhesion assay as this ®nding was
con®rmed by a second adhesion assay in which centrifugal force
rather than repeated washes was used to separate adherent from
nonadherent cells (Calof and Lander, 1991). By FACS analysis
human keratinocytes did not express avb3. In contrast, human
bladder carcinoma T24 cells that expressed avb3 (Senger et al,
1994) did adhere to ®brin. Human umbilical vein endothelial cells
(Cheresh, 1987), human dermal ®broblasts (Gailit and Clark, 1996)
and human microvascular endothelial cells (Enenstein et al, 1992;
Klein et al, 1993; Sepp et al, 1994) also express avb3 and bind
®brinogen and ®brin (Cheresh, 1987; Gailit and Clark, 1996;
Figure 8. Immuno¯uorescence staining and
FACS analysis for avb3 integrin receptor on
keratinocytes transduced with b3 cDNA and
b-gal cDNA. (a, c) b3 cDNA; (b, d) b-gal
cDNA. Fourth passage-transduced keratinocytes
were cultured in KGM for 5 d on LAB-TEK
tissue culture chamber, ®xed with 2% paraform-
aldehyde for 10 min, and stained with monoclonal
antibody to avb3 (23C6), biotinylated anti-mouse
IgG and ¯uorescein streptavidin. Cell nuclei were
counterstained with 0.1% paraphenylenediamine
mounting buffer (Welch et al, 1990). FACS
analysis was also performed on fourth passage-
transduced keratinocytes cultured in KGM. The
cell surface expression of avb3 was analyzed by
¯ow cytometry performed with a FACStar Plus
cell sorter.
Figure 9. Cell adhesion of b3 integrin
subunit cDNA-transduced and b-gal cDNA-
transduced keratinocytes (control) to
®brinogen, ®brin, vitronectin, ®bronectin,
and type I collagen. Cell adhesion assay was
done by method 1. One 3 104 viable cells were
added to the wells coated with 100 mg ®brinogen
per ml (coated at 37°C overnight), 100 mg ®brin
per ml, 10 mg vitronectin per ml, 20 mg
®bronectin per ml, 20 mg type I collagen (COL-
1) per ml. Percent adhesion was calculated from
the net OD value (total OD minus BSA control)
of experimental conditions divided by the net OD
value of maximal adhesion on poly L-lysine (total
OD minus BSA control). Data points are the
mean 6 SD of quadruplicate samples. The results
presented here are representative of three
independent experiments. Adhesion of b3 cDNA-
transduced keratinocytes to ®brinogen, ®brin,
vitronectin, and ®bronectin was signi®cantly
greater than the adhesion of b cDNA-gal-trans-
duced keratinocytes to these surfaces as judged by
the two-tailed Student's t-test (p < 0.001 for
®brinogen, ®brin, and vitronectin; p < 0.01 for
®bronectin).
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Newman et al 19961). In parallel studies the same adhesion assay
that detected ®broblast (Gailit et al, 1997), and microvascular
endothelial cell adhesion (Newman et al 19961) to ®brin and
®brinogen, detected no keratinocyte attachment to ®brin or
®brinogen. Thus, the possibility that different assay conditions
contributed to the differential ®ndings among these three cell types
is extremely unlikely.
Keratinocyte adhesion to ®brin, ®brinogen or its fragments could
not be stimulated by biologic response modi®ers, such as TGF-b,
EGF, TPA, dibutyryl cyclic AMP, or cation alterations, which
induce or activate integrin expression in other situations. TGF-b
stimulated avb3 expression in ®broblasts (Ignotz et al, 1989) and
increased av and a5b1 expression in keratinocytes (Gailit et al,
1994). In this study, TGF-b enhanced keratinocyte adhesion to
®bronectin 2-fold (data not shown) but did not induce adhesion to
®brin or ®brinogen. EGF induced a2b1 on human keratinocytes
and stimulated both adhesion and migration on type I collagen
(Chen et al, 1993), but not adhesion to ®brin or ®brinogen in this
study. TPA induced a2 mRNA in ®broblasts (Xu et al, 1996) and
in this study increased keratinocyte adhesion to type IV collagen, a
known ligand for a2b1 (Carter et al, 1990), but not to ®brin or
®brinogen. MgCl2 activated a2b1 integrin receptors in keratino-
cytes (Grzesiak and Pierschbacher, 1995) and in this study enhanced
keratinocyte binding to type I and IV collagen, but not ®brin or
®brinogen. CaCl2 activated avb3 integrin-mediated cell migration
in endothelial cells (Leavesley et al, 1993), but did not induce
adhesion to ®brin or ®brinogen in this study.
As ®bronectin is a substantial component of the in vivo ®brin clot,
human keratinocytes were tested for their ability to interact with
composites of ®bronectin and ®brin or ®brinogen. Surprisingly, at
physiologic 1:10 molar ratios of ®bronectin to ®brin or ®brinogen,
keratinocytes were unable to interact with ®bronectin. Even at a
1:1 molar ratio, adhesion of keratinocytes to the composite was
markedly diminished compared with keratinocyte adhesion to the
equivalent amount of ®bronectin adsorbed alone on the surface.
These data were not attributable to ®brin or ®brinogen preventing
®bronectin from adsorbing to the plastic surface of wells as judged
by both isotopic and enzyme-linked streptavidin±biotin assays.
Figure 10. Fibrin is anti-adhesive for kera-
tinocytes. Cell morphology of the b3 integrin
subunit cDNA-transduced keratinocytes (denoted
as b3 in column 1) and b-gal cDNA-transduced
keratinocytes (denoted as b-gal in column 2)
(control) after 1 h cell adhesion assay to 100 mg
®brinogen per ml (coated at 37°C overnight),
100 mg ®brin per ml, 10 mg vitronectin per ml,
20 mg ®bronectin per ml, and 20 mg type I
collagen (COL-1) per ml. Cells were ®xed with
1% glutaraldehyde for 10 min and stained with
0.1% crystal violet in 0.2 M MES, pH 6.0 for
20 min.
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Thus, ®brin and ®brinogen are clearly anti-adhesives for keratino-
cytes in that they prevent interaction of the cells to a substrate for
which they otherwise have great avidity (Chiquet-Ehrismann,
1990). Preliminary ELISA experiments with a monoclonal anti-
body whose epitope is near the ®bronectin RGD domain suggests
that ®brinogen/®brin mask the ®bronectin-binding site for a5b1.
Ultimately, the goal is to understand keratinocyte migration
during wound healing. As a ®rst step we monitored single cell
migration over a protein coated surface using a modi®cation
(Woodley, 1996) of the Albrecht-Buehler phagokinetic assay
(Albrecht-Buehler, 1977). In this assay ®brinogen-coated surfaces
failed to promote keratinocyte migration. Outmigration of strati-
®ed epidermal cells from a skin explant over hydrated three-
dimensional ECM simulates re-epithelialization better than single
cell movement over a protein-coated surface. The dif®culty with
this paradigm, however, is that a longer incubation (3 d) is
necessary compared with the phagokinetic assay (hours). The
extended incubation allows keratinocytes time to synthesize and
deposit new ECM proteins in the extracellular environment that
they can do in vitro (Kubo et al, 1984; O'Keefe et al, 1984) and
in vivo (Grimwood et al, 1988). Despite this potential complication,
keratinocyte outgrowth over a ®brin gel was modest compared
with migration over a type I collagen gel. The ®nding that strati®ed
epidermal outgrowth moves poorly over a ®brin gel compared with
a collagen gel is in concert with in vivo observations that the wound
epidermis prefers to migrate along the collagen surface of the cut
dermis rather than over or through the ®brin clot.
Human keratinocytes may fail to attach and migrate on
®brinogen or ®brin through their lack of avb3 integrin receptor.
Indeed, this possibility was established by the observation that
transduction of b3 cDNA into normal human keratinocytes
conferred on them the ability to attach and spread on ®brinogen
or ®brin. b3 cDNA-transduced keratinocytes also attached to and
spread on vitronectin signi®cantly more than the control cells.
Attachment of b3 cDNA-transduced keratinocytes to ®brin was
inhibited by RGD, but not RGE peptides. Fibrin has three RGD-
like peptides: RGDF, RGDS, and QAGDV (Cheresh et al, 1989).
RGDF and RGDS reside on the ®brin a chain, whereas QAGDV
resides on the g chain. RGDS mediates human umbilical vein
endothelial cell binding to ®brinogen and ®brin through avb3,
QAGDV mediates platelet binding to ®brinogen and ®brin through
aIIbb3, whereas RGDF has no known function (Cheresh et al,
1989). Further studies will be needed to address whether b3-
transducted keratinocytes bind one, two, or all of these RGD-like
sites on ®brinogen. LM609, a monoclonal antibody to avb3,
blocked b3 cDNA-transduced keratinocyte adhesion to ®brin,
whereas monoclonal antibody 16, a monoclonal blocking antibody
of the ®bronectin a5b1 integrin receptor (Akiyama et al, 1989), did
not block adhesion. From these data we conclude that the inability
of normal human keratinocytes to interact with ®brinogen and
®brin is due to their lack of avb3 integrin receptor. The absence of
this receptor may be one of the fundamental reasons why the
migrating epidermis dissects the ®brin clot from viable tissue during
wound healing and results in a slough of the ®brin eschar.
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